68.92
Finanzdaten der Boston Scientific Corp-Aktie (BSX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
4.36%
5,286.00
|
5,065.00 | 5,061.00 | 4,663.00 | 4,561.00 |
| Cost Of Revenue |
5.58%
1,608.00
|
1,523.00 | 1,637.00 | 1,453.00 | 1,466.00 |
| Gross Profit |
3.87%
3,679.00
|
3,542.00 | 3,424.00 | 3,210.00 | 3,095.00 |
|
|
14.43%
2,854.00
|
2,494.00 | 2,605.00 | 2,288.00 | 2,420.00 |
| Interest Income/Expense |
3.45%
90.00
|
87.00 | 90.00 | 82.00 | 80.00 |
| Benefits Costs and Expenses |
11.15%
4,586.00
|
4,126.00 | 4,120.00 | 3,858.00 | 3,976.00 |
| Costs And Expenses |
11.15%
4,586.00
|
4,126.00 | 4,120.00 | 3,858.00 | 3,976.00 |
| Operating Income/Loss |
21.28%
825.00
|
1,048.00 | 819.00 | 921.00 | 675.00 |
| Income/Loss From Continuing Operations Before Tax |
25.45%
700.00
|
939.00 | 941.00 | 805.00 | 585.00 |
| Income Tax Expense/Benefit |
83.61%
30.00
|
183.00 | 146.00 | 133.00 | 23.00 |
| Income/Loss From Continuing Operations After Tax |
11.38%
670.00
|
756.00 | 795.00 | 672.00 | 562.00 |
|
|
11.26%
670.00
|
755.00 | 795.00 | 672.00 | 562.00 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-2.00
|
- | -2.00 | -2.00 | -12.00 |
| Basic Average Shares |
99.95%
0.80
|
1,481.70 | 1,479.90 | 1,477.20 | 0.90 |
| Diluted Average Shares |
99.97%
0.50
|
1,495.50 | 1,493.50 | 1,493.10 | 1.40 |
| Basic Earnings Per Share |
9.80%
0.46
|
0.51 | 0.54 | 0.46 | 0.38 |
| Diluted Earnings Per Share |
11.76%
0.45
|
0.51 | 0.53 | 0.45 | 0.38 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):